Dae Hwa Pharm Co (XKRX:067080) Net Change in Cash : ₩-2,691 Mil (TTM As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Dae Hwa Pharm Co's Net Change in Cash for the three months ended in Dec. 2024 was ₩-3,179 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-2,691 Mil.

Dae Hwa Pharm Co Net Change in Cash Historical Data

The historical data trend for Dae Hwa Pharm Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Net Change in Cash Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

712.90

591.24

-876.60

1,224.43

-2,691.07

Dae Hwa Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															614.24	-1,452.25	986.72	953.80	-3,179.35

Dae Hwa Pharm Co Net Change in Cash Calculation

Dae Hwa Pharm Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	5249.711	+	5269.727	+	-14087.125	+	876.613
	=	-2,691

Dae Hwa Pharm Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 1751.177 + 3201.313 + -8699.819 + 567.982

= -3,179

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,691 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dae Hwa Pharm Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Net Change in Cash

Comparable Companies

XKRX:033270 XKRX:256840 XKRX:243070 XKRX:000520 XKRX:003220 XKRX:003000 XKRX:389470 XKRX:476060 XKRX:176750 XKRX:249420 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines